Understanding hirsutism in PCOS

References

• Franks S. The investigation and management of hirsutism. J Fam Plann Reprod Health Care. 2012 Jul;38(3):182–6. doi: 10.1136/jfprhc-2011-100175
   PubMedGoogle Scholar
• Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961 Nov;21(11):1440–7. doi: 10.1210/jcem-21-11-1440
   PubMed Web of Science ®Google Scholar
• Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998 Sep;83(9):3078–3082.
   PubMed Web of Science ®Google Scholar
• McCartney Ch R, Marshall JC, Solomon CG. Polycystic ovary syndrome. N Engl J Med. 2016 Oct 6;375(1):54–64. doi: 10.1056/NEJMcp1514916
   PubMed Web of Science ®Google Scholar
• Yildiz BO, Bolour S, Woods K, et al. Visually scoring hirsutism. Hum Reprod Update. 2010 Jan;16(1):51–64.
   PubMed Web of Science ®Google Scholar
• Chin HB, Marsh EE, Hall JE, et al. Prevalence of hirsutism among reproductive-aged African American women. J Womens Health (Larchmt). 2021 Nov;30(11):1580–1587.
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004 Jun;89(6):2745–9.
   PubMed Web of Science ®Google Scholar
• Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1233–1257. doi: 10.1210/jc.2018-00241
   PubMed Web of Science ®Google Scholar
• Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med. 2005 Dec 15;353(24):2578–2588. doi: 10.1056/NEJMcp033496
   PubMedGoogle Scholar
• Inui S, Itami S. Androgen actions on the human hair follicle: perspectives. Exp Dermatol. 2013 Mar;22(3):168–71. doi: 10.1111/exd.12024
   PubMed Web of Science ®Google Scholar
• Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004 Feb;89(2):453–62.
   PubMed Web of Science ®Google Scholar
• Oliveira TF, Oliveira TF, Rocha ALL, et al. Comparison of image-based modified Ferriman-Gallway score evaluation with in-person evaluation: an alternative method for hirsutism diagnosis. Arch Dermatol Res. 2023 Aug;315(6):1783–1787.
   PubMed Web of Science ®Google Scholar
• Pasch L, He SY, Huddleston H, et al. Clinician vs self-ratings of hirsutism in patients with polycystic ovarian syndrome: associations with quality of life and depression. JAMA Dermatol. 2016 Jul 1;152(7):783–8. doi: 10.1001/jamadermatol.2016.0358
   PubMed Web of Science ®Google Scholar
• Legro RS, Schlaff WD, Diamond MP, et al. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab. 2010 Dec;95(12):5305–13.
   PubMed Web of Science ®Google Scholar
• Morales AJ, Laughlin GA, Butzow T, et al. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab. 1996 Aug;81(8):2854–2864.
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007 Aug 25;370(9588):685–97. doi: 10.1016/S0140-6736(07)61345-2
   PubMed Web of Science ®Google Scholar
• Kumar A, Woods KS, Bartolucci AA, et al. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2005 Jun;62(6):644–9.
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo RA. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. J Endocrinol Invest. 2007 Feb;30(2):111–6. doi: 10.1007/BF03347408
   PubMed Web of Science ®Google Scholar
• Patton WC, Berger MJ, Thompson IE, et al. Pituitary gonadotropin responses to synthetic luteinizing hormone-releasing hormone in patients with typical and atypical polycystic ovary disease. Am J Obstet Gynecol. 1975 Feb 1;121(3):382–6. doi: 10.1016/0002-9378(75)90017-4
   PubMed Web of Science ®Google Scholar
• Panghiyangani R, Soeharso P, Suryandari DA, et al. CYP19A1 gene expression in patients with polycystic ovarian syndrome. J Hum Reprod Sci. 2020 Apr;13(2):100–103.
   PubMedGoogle Scholar
• Naessen T, Kushnir MM, Chaika A, et al. Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry. Fertil Steril. 2010 Nov;94(6):2228–33.
   PubMed Web of Science ®Google Scholar
• Young JM, McNeilly AS. Theca: the forgotten cell of the ovarian follicle. Reproduction. 2010 Oct;140(4):489–504. doi: 10.1530/REP-10-0094
   PubMed Web of Science ®Google Scholar
• Comim FV, Hardy K, Franks S, et al. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLos One. 2013;8(11):e80416. doi: 10.1371/journal.pone.0080416
   PubMed Web of Science ®Google Scholar
• Wickenheisser JK, Nelson-Degrave VL, McAllister JM. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 Mar;90(3):1720–1727. doi: 10.1210/jc.2004-1860
   PubMed Web of Science ®Google Scholar
• Xing C, Zhang J, Zhao H, et al. Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment. Int J Womens Health. 2022;14:91–105. doi: 10.2147/IJWH.S344542
   PubMed Web of Science ®Google Scholar
• Burger HG. Androgen production in women. Fertil Steril. 2002 Apr;77(Suppl 4):S3–5. doi: 10.1016/S0015-0282(02)02985-0
   PubMed Web of Science ®Google Scholar
• Wang L, Li S, Zhao A, et al. The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients. J Steroid Biochem Mol Biol. 2012 Oct;132(1–2):120–6.
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Shah NA, Antoine HJ, et al. Variants in the 5 alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab. 2006 Oct;91(10):4085–4091.
   PubMed Web of Science ®Google Scholar
• Skalba P, Dabkowska-Huc A, Kazimierczak W, et al. Content of 5-alpha-reductase (type 1 and type 2) mRNA in dermal papillae from the lower abdominal region in women with hirsutism. Clin Exp Dermatol. 2006 Jul;31(4):564–70.
   PubMed Web of Science ®Google Scholar
• Oliveira IO, Lhullier C, Brum IS, et al. Gene expression of type 2 17 beta hydroxysteroid dehydrogenase in scalp hairs of hirsute women. Steroids. 2003 Sep;68(7–8):641–649.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447–2469. doi: 10.1210/clinem/dgad463
   PubMedGoogle Scholar
• Hatch R, Rosenfield RL, Kim MH, et al. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981 Aug 1;140(7):815–30. doi: 10.1016/0002-9378(81)90746-8
   PubMed Web of Science ®Google Scholar
• Tellez R, Frenkel J. Clinical evaluation of body hair in healthy women. Rev Med Chil. 1995 Nov;123(11):1349–1354.
   PubMed Web of Science ®Google Scholar
• Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000 Jul;85(7):2434–2438.
   PubMed Web of Science ®Google Scholar
• Cheewadhanaraks S, Peeyananjarassri K, Choksuchat C. Clinical diagnosis of hirsutism in Thai women. J Med Assoc Thai. 2004 May;87(5):459–63.
   PubMedGoogle Scholar
• Sagsoz N, Kamaci M, Orbak Z. Body hair scores and total hair diameters in healthy women in the kirikkale region of Turkey. Yonsei Med J. 2004 Jun 30;45(3):483–491. doi: 10.3349/ymj.2004.45.3.483
   PubMed Web of Science ®Google Scholar
• DeUgarte CM, Woods KS, Bartolucci AA, et al. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab. 2006 Apr;91(4):1345–50.
   PubMed Web of Science ®Google Scholar
• Api M, Badoglu B, Akca A, et al. Interobserver variability of modified ferriman-gallwey hirsutism score in a Turkish population. Arch Gynecol Obstet. 2009 Apr;279(4):473–479.
   PubMed Web of Science ®Google Scholar
• K NM. Prevalence of hirsutism in adolescent girls in YAzd, Iran. Iran Crescent Red Journal. 2010;12:111–117.
   Web of Science ®Google Scholar
• Kim JJ, Chae SJ, Choi YM, et al. Assessment of hirsutism among Korean women: results of a randomly selected sample of women seeking pre-employment physical check-up. Hum Reprod. 2011 Jan;26(1):214–20.
   PubMed Web of Science ®Google Scholar
• Zhao X, Ni R, Li L, et al. Defining hirsutism in Chinese women: a cross-sectional study. Fertil Steril. 2011 Sep;96(3):792–6.
   PubMed Web of Science ®Google Scholar
• Döner N, Ekmekçi TR. Criticising modified ferriman-gallwey scoring system in the evaluation of hirsutism in 1034 Turkish women. Turkiye Klinikleri. 2013;33:314–320.
   Google Scholar
• Karimah P HAIMJ, Lunenfeld B, Tzeng CR The cut off of ferriman gallwey score for PCOS in Asia and the degree of hyperandrogenism indicator. The 6th congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2016) Jakarta, ID. Dubai: Knowledge E; 2016.
   Google Scholar
• Ilagan M, Paz-Pacheco E, Totesora DZ, et al. The modified ferriman-gallwey score and hirsutism among Filipino women. Endocrinol Metab (Seoul). 2019 Dec;34(4):374–381.
   PubMedGoogle Scholar
• Naranjo Cardona AL, Montilla Garzón JC, Sepúlveda Gallego LE. Evaluación clínica de vello corporal terminal y prevalencia de hirsutismo en estudiantes universitarias de la ciudad de Manizales (Caldas), 2012. Biosalud. 2015;14(1):36–43. doi: 10.17151/biosa.2015.14.1.4
   Google Scholar
• Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2013 Jun;98(6):E1088–96. doi: 10.1210/jc.2013-1295
   PubMed Web of Science ®Google Scholar
• TC MA, Teede H Technical report for the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Monash University; 2023.
   Google Scholar
• Kiconco S, Mousa A, Azziz R, et al. PCOS phenotype in unselected populations study (P-PUP): protocol for a systematic review and defining PCOS diagnostic features with pooled individual participant data. Diagnostics (Basel). 2021 Oct 21;11(11):1953. doi: 10.3390/diagnostics11111953
   PubMedGoogle Scholar
• Huang Z, Yong EL. Ethnic differences: is there an Asian phenotype for polycystic ovarian syndrome? Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:46–55. doi: 10.1016/j.bpobgyn.2016.04.001
   PubMed Web of Science ®Google Scholar
• Mani H, Davies MJ, Bodicoat DH, et al. Clinical characteristics of polycystic ovary syndrome: investigating differences in white and South Asian women. Clin Endocrinol (Oxf). 2015 Oct;83(4):542–9.
   PubMed Web of Science ®Google Scholar
• Ding T, Baio G, Hardiman PJ, et al. Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study. BMJ Open. 2016 Jul 11;6(7):e012461. doi: 10.1136/bmjopen-2016-012461
   PubMed Web of Science ®Google Scholar
• Skiba MA, Islam RM, Bell RJ, et al. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018 Nov 1;24(6):694–709. doi: 10.1093/humupd/dmy022
   PubMed Web of Science ®Google Scholar
• Gibson-Helm M, Teede H, Dunaif A, et al. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017 Feb 1;102(2):604–612. doi: 10.1210/jc.2016-2963
   PubMed Web of Science ®Google Scholar
• van Keizerswaard J, de Loos ALP D, Louwers YV, et al. Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study. Fertil Steril. 2022 May;117(5):1059–1066.
   PubMed Web of Science ®Google Scholar
• Ireland K, Child T. Polycystic ovary syndrome and the postmenopausal woman. J Br Menopause Soc. 2006 Dec;12(4):143–8. doi: 10.1258/136218006779160580
   PubMedGoogle Scholar
• Rosner W, Auchus RJ, Azziz R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab. 2007 Feb;92(2):405–13.
   PubMed Web of Science ®Google Scholar
• Turcu AF, Rege J, Auchus RJ, et al. 11-oxygenated androgens in health and disease. Nat Rev Endocrinol. 2020 May;16(5):284–296.
   PubMed Web of Science ®Google Scholar
• O’Reilly MW, Kempegowda P, Jenkinson C, et al. 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome. J Clin Endocrinol Metab. 2017 Mar 1;102(3):840–848. doi: 10.1210/jc.2016-3285
   PubMed Web of Science ®Google Scholar
• Nanba AT, Rege J, Ren J, et al. 11-oxygenated C19 steroids do not decline with age in women. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2615–2622. doi: 10.1210/jc.2018-02527
   PubMed Web of Science ®Google Scholar
• Rege J, Garber S, Conley AJ, et al. Circulating 11-oxygenated androgens across species. J Steroid Biochem Mol Biol. 2019 Jun;190:242–249.
   PubMed Web of Science ®Google Scholar
• Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020 Nov 1;26(6):942–960. doi: 10.1093/humupd/dmaa029
   PubMed Web of Science ®Google Scholar
• Kumarendran B, Sumilo D, O’Reilly MW, et al. Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study. Eur J Endocrinol. 2019 Apr;180(4):265–272.
   PubMed Web of Science ®Google Scholar
• Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012 Nov;18(6):618–637.
   PubMed Web of Science ®Google Scholar
• Zhu S, Zhang B, Jiang X, et al. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2019 Jan;111(1):168–177.
   PubMed Web of Science ®Google Scholar
• Shengir M, Chen T, Guadagno E, et al. Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: a systematic review and meta-analysis. JGH Open. 2021 Apr;5(4):434–445.
   PubMed Web of Science ®Google Scholar
• Sonino N, Fava GA, Mani E, et al. Quality of life of hirsute women. Postgrad Med J. 1993 Mar;69(809):186–9.
   PubMed Web of Science ®Google Scholar
• Fava GA, Grandi S, Savron G, et al. Psychosomatic assessment of hirsute women. Psychother Psychosom. 1989;51(2):96–100. doi: 10.1159/000288142
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003 Dec;88(12):5801–7.
   PubMed Web of Science ®Google Scholar
• McCook JG, Reame NE, Thatcher SS. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2005 Jan;34(1):12–20. doi: 10.1177/0884217504272945
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Benson S, Hahn S, et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod. 2006 Apr;21(4):1092–9.
   PubMed Web of Science ®Google Scholar